We are live on ! Find out more
PCML

Pavaki Capital Management LLC Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+12.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$245M
Cap. Flow %
95.8%
Top 10 Hldgs %
57.32%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$13.2M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$11.4M
4
B
Barrick Mining
B
+$7.28M
5
DIS icon
Walt Disney
DIS
+$6.72M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 29.54%
2 Materials 10.85%
3 Communication Services 4.97%
4 Technology 3.95%
5 Industrials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLNG icon
126
Dynagas LNG Partners
DLNG
$137M
$113K 0.04%
+30,000
New +$110K
WPP icon
127
WPP
WPP
$5.94B
$112K 0.04%
+5,000
New +$108K
AKO.B icon
128
Embotelladora Andina Series B
AKO.B
$4.95B
$112K 0.04%
+4,000
New +$104K
GGB icon
129
Gerdau
GGB
$9.7B
$93K 0.04%
+25,200
New +$88.1K
BRK.B icon
130
Berkshire Hathaway Class B
BRK.B
$1.13T
$50.3K 0.02%
+100
New +$49.8K
SPRY icon
131
CALL
ARS Pharmaceuticals
SPRY
$612M
$17.5K 0.01%
+1,500
New +$14.6K
2 3 4 5
6

Similar funds

GCM
GoodHaven Capital Management Millburn, New Jersey $287M AUM 9.07% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $287M AUM 29.75% 1-Year Est. Return
EA
Extract Advisors Calabasas, California $287M AUM
MAG
Mayfair Advisory Group Birmingham, Alabama $286M AUM 19.6% 1-Year Est. Return
PAM
PSquared Asset Management Zurich, Switzerland $287M AUM 58.62% 1-Year Est. Return
MM
Marnell Management Farmington Hills, Michigan $288M AUM
FCG
Financial Connections Group Corte Madera, California $288M AUM 15.87% 1-Year Est. Return
A
Argentarii Cincinnati, Ohio $286M AUM 32.04% 1-Year Est. Return

Pavaki Capital Management LLC's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Pavaki Capital Management LLC, which disclosed 131 positions worth $255M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Materials and Communication Services.

  • Pavaki Capital Management LLC's largest Q4 2025 buy was Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
  • Pavaki Capital Management LLC's ten largest holdings make up 57% of its $255M portfolio in Q4 2025.
  • Pavaki Capital Management LLC disclosed 131 positions in Q4 2025, its first 13F filing on record.

Based on Pavaki Capital Management LLC's 13F filing for Q4 2025, filed 7 Aug 2026.